Ariane M. Davison Email & Phone Number

San Francisco, CA, US

EMCIF is the first dedicated US venture capital fund to address immense global inequity in oncology therapeutics, treatment and care. We invest in US and EU based cancer start-ups who are keen to explore emerging markets or engage in collaborative R&D. We address the critical bottlenecks in both established and emerging markets that limit access and.

New York, NY, US

Originate and execute intensive due diligence projects for high-profile stakeholders as Strategist for Healthcare, I-O, and all therapeutic modalities under clinical development. Content creator and expert moderator focusing on US and APAC biotechnology, therapeutics, oncology, emerging technologies, US/China policies, collaborations and relations.Founded.

New York, NY, US

Originate and execute intensive due diligence projects for high-profile stakeholders as Strategist for Healthcare, I-O, and all therapeutic modalities under clinical development. Content creator and expert moderator focusing on US and APAC biotechnology, therapeutics, oncology, emerging technologies, US/China policies, collaborations and relations.Founded.

Singapore, SG

Hummingbird Bioscience is leading the field with a bold new way of engineering precision oncology and infectious disease biotherapeutics that define the future of precision medicine. Hummingbird focuses on critical and difficult-to-drug biologically validated targets in cancer and autoimmune disease.Powered by unique patented AI and data-driven system.

Singapore, SG

Hummingbird Bioscience is a highly innovative biotech company applying advances in systems and computational biology to rapidly develop antibodies into successful oncology therapeutics for difficult to drug targets.

Central, HK

• In a dedicated 5-part series, Ariane investigated and reported on the development of COVID-19, key global health issues challenging the world and how blockchain technology can and will continue to impact efficiency.
• Virus structure and immunology, facemasks and PPE
• Staying safe during travel, testing, tracking
• Anti-viral antibodies, vaccines, mRNA technology, antiviral drugs, clinical trial development
• Supply chain and delivery logistics. All with a perspective of how blockchain technology is revolutionizing the healthcare industry.ForKast.News is a visionary news platform founded by ex-Bloomberg anchor, Angie Lau.

• Highly specialized medical investment advisor to VC / PE / HNW clients on:
• Private and public US / Asia / Global biotech investments
• Comprehensive due diligence on biotechs, technologies and platforms, competitor analyses
• Deal Flow - Matching and connecting global biotech investment opportunities to appropriate VC / PE funds
• Advising US and Australian biotech companies on China market entry strategy.
• Co-consulting with US biotech consulting firms on China market opportunities for both private and US NASDAQ-listed biotechs.Areas of Expertise:

Pacific GeneTech develops disruptive recombinant animal and human food-safety vaccines and adjuvant / delivery systems for global markets develops and commercializes first-in-class or best-in-class vaccines for areas of high unmet or underserved needs in food safety and animal health. The global animal vaccine market is a valuable opportunity, growing at.

Shanghai, CN

China Blue Sky Partners has a fundamental understanding of China healthcare, regulatory and political systems, and supports the commercialization of high-potential Australian biotechs into the China Markets through capital raising via China and Hong Kong VC/PE and philanthropic funds, and the development of strong and reputable investment and strategic.

Palo Alto, CA, US

The Kauffman Venture Capital Fellowship is a highly sought-after networking and educational program dedicated exclusively to the world of venture capital and the cultivation of new high-impact companies. Only 30 high calibre individuals are selected as Kauffman Finalists each year, with selection signaling membership among an elite cadre of the world's.

• Supporting the set-up and launch of a new healthcare/biotech L/S hedge fund in Hong Kong dedicated to US and emerging market healthcare equities (Hong Kong HSI, USA NYSE/NASDAQ, India, SGX Singapore, TSWE Taiwan, South.
• Operational - Master fund set-up, PPM, investor relations, monthly performance updates
• Compliance and licence processes
• Website development and launch
• Development of Excel / Bloomberg tools to automate stock screening.
• Developed relative valuation methodologies to identify over/under-valued stocks.

Hong Kong, Hong Kong, HK

A Goldman Sachs-invested biotech (Filligent Pty Ltd) developing and commercializing anti-microbial and anti-viral facemasks, PPE and medical devices for the hospital, military (DOD/BARDA) and consumer industries. Ariane secured a First In Class De Novo 510(k) US FDA approval for the “BioMask” (K101128). The US FDA created a new medical device.

Hong Kong, Hong Kong, HK

A Goldman Sachs-invested biotech (Filligent Pty Ltd) developing and commercializing anti-microbial and anti-viral facemasks, PPE and medical devices for the hospital, military (DOD/BARDA) and consumer industries. Ariane secured a First In Class De Novo 510(k) US FDA approval for the “BioMask” (K101128). The US FDA created a new medical device.

The University Of Sydney, New South Wales, AU

Continuation of MD/Ph.D. focus of virus dermatological infection model, leading to viral encephalitis. Investigating the role and ontogeny of dendritic cells in the initiation and modulation of CD4+ and CD8+ T cell immunity to virus-infected stem cells, and immunomodulation via cytokine/chemokine administration and neutralization. Experience with WNV, JEV.

The University Of Sydney, New South Wales, AU

Training postgraduate medical students in multi-disciplinary faculties including differential diagnoses, treatment and scientific mechanisms of complex medical cases: Endocrinology, Pathology, Musculoskeletal, Cardiology, Gastroenterology, Neurology, Urology, Pharmacology.

The University Of Sydney, New South Wales, AU

Investigation of microbial genetics in order to improve the specificity by which the epidemiology of global infectious disease outbreaks can be tracked, and efficiently contained. Journal publications. Medical Proficiencies: Genetic techniques (AFLP/RFLP, cloning), RT-PCR, Radioactive PCR, gel electrophoresis, phage typing, cell culture, gene sequencing.

Doctor Of Medicine, Medicine - Immunology, Immunotherapy & Vaccines

B.Sc. (Hons), Molecular And Microbial Genetics - Epidemiology

Bachelor Of Medical Science, Genetics, Biochemistry, Biology, Medical Microbiology, Pharmacology, Pharmacodynamics

Mba - Business Course